Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
Amalgent Therapeutics, LLC has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $2,800,543 between 2023 and 2024. These are non-dilutive federal research grants, not equity financing. The company is based in Chapel Hill, North Carolina.
No investors recorded yet for Amalgent Therapeutics, LLC.
Add an investorAmalgent Therapeutics, LLC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Amalgent Therapeutics, LLC.
Add diversity data